Paul Nunn

Summary

Affiliation: World Health Organization
Country: Switzerland

Publications

  1. ncbi The research agenda for improving health policy, systems performance, and service delivery for tuberculosis control: a WHO perspective
    Paul Nunn
    Tuberculosis Strategy and Operations, Stop TB Department, World Health Organization, Switzerland
    Bull World Health Organ 80:471-6. 2002
  2. ncbi Tuberculosis and HIV infection: the global setting
    Paul Nunn
    Stop TB Department, World Health Organization, Geneva, Switzerland
    J Infect Dis 196:S5-14. 2007
  3. ncbi Tuberculosis control in the era of HIV
    Paul Nunn
    Stop TB Department, World Health Organization, Via Appia 27, CH 1211, Geneva 12, Switzerland
    Nat Rev Immunol 5:819-26. 2005
  4. ncbi Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance
    Abigail Wright
    Stop TB Department, WHO, Geneva, Switzerland
    Lancet 373:1861-73. 2009
  5. ncbi Scaling up interventions to achieve global tuberculosis control: progress and new developments
    Mario Raviglione
    Stop TB Department, WHO, Geneva, Switzerland
    Lancet 379:1902-13. 2012
  6. ncbi Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration
    Alasdair Reid
    Stop TB Department, WHO, Geneva, Switzerland
    Lancet Infect Dis 6:483-95. 2006
  7. ncbi Patients with previously treated tuberculosis no longer neglected
    Matteo Zignol
    Stop TB Department, World Health Organization, Geneva, CH 1211, Switzerland
    Clin Infect Dis 44:61-4. 2007
  8. ncbi Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis
    Mohamed Abdel Aziz
    Stop TB Department, WHO, Geneva, Switzerland
    Lancet 368:2142-54. 2006
  9. ncbi Tuberculosis and air travel: WHO guidance in the era of drug-resistant TB
    Lindsay Martinez
    Stop TB Department, World Health Organization, 1211 Geneva 27, Switzerland
    Travel Med Infect Dis 6:177-81. 2008
  10. ncbi Tb drug resistance: is it really a threat to Africa?
    Paul Nunn
    World Health Organization, Stop TB Department, Avenue Appia 1211 Geneva, Switzerland
    Ethiop Med J 45:399-404. 2007

Detail Information

Publications21

  1. ncbi The research agenda for improving health policy, systems performance, and service delivery for tuberculosis control: a WHO perspective
    Paul Nunn
    Tuberculosis Strategy and Operations, Stop TB Department, World Health Organization, Switzerland
    Bull World Health Organ 80:471-6. 2002
    ..We discuss the prerequisites for success, the shortcomings of this WHO- supported programme, and future challenges and needs...
  2. ncbi Tuberculosis and HIV infection: the global setting
    Paul Nunn
    Stop TB Department, World Health Organization, Geneva, Switzerland
    J Infect Dis 196:S5-14. 2007
    ..The TB and HIV communities should join forces to address the health-sector weaknesses that confront them both...
  3. ncbi Tuberculosis control in the era of HIV
    Paul Nunn
    Stop TB Department, World Health Organization, Via Appia 27, CH 1211, Geneva 12, Switzerland
    Nat Rev Immunol 5:819-26. 2005
    ..As a consequence, global TB control policies have had to be revised and control of TB now demands increased investment. This paper assesses what is being done to address the issue and what remains to be done...
  4. ncbi Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance
    Abigail Wright
    Stop TB Department, WHO, Geneva, Switzerland
    Lancet 373:1861-73. 2009
    ..The Global Project on Anti-Tuberculosis Drug Resistance has been gathering data since 1994. This study provides the latest data on the extent of drug resistance worldwide...
  5. ncbi Scaling up interventions to achieve global tuberculosis control: progress and new developments
    Mario Raviglione
    Stop TB Department, WHO, Geneva, Switzerland
    Lancet 379:1902-13. 2012
    ..International and national financial uncertainty places gains at serious risk. Perseverance and renewed commitment are needed to achieve global control of tuberculosis, and ultimately, its elimination...
  6. ncbi Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration
    Alasdair Reid
    Stop TB Department, WHO, Geneva, Switzerland
    Lancet Infect Dis 6:483-95. 2006
    ....
  7. ncbi Patients with previously treated tuberculosis no longer neglected
    Matteo Zignol
    Stop TB Department, World Health Organization, Geneva, CH 1211, Switzerland
    Clin Infect Dis 44:61-4. 2007
    ..Previously treated patients are difficult to re-treat and represent an important source of disease transmission, as well as a serious threat to TB control worldwide, because of their higher rate of drug resistance...
  8. ncbi Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis
    Mohamed Abdel Aziz
    Stop TB Department, WHO, Geneva, Switzerland
    Lancet 368:2142-54. 2006
    ..Gaps in coverage of the Global Project are substantial, and baseline information is urgently required from several countries with high tuberculosis burden to develop appropriate control interventions...
  9. ncbi Tuberculosis and air travel: WHO guidance in the era of drug-resistant TB
    Lindsay Martinez
    Stop TB Department, World Health Organization, 1211 Geneva 27, Switzerland
    Travel Med Infect Dis 6:177-81. 2008
    ..Following several recent incidents involving MDR-TB and XDR-TB in airline passengers, the 2006 recommendations will be amplified in the light of experience gained and the evolving epidemiological situation...
  10. ncbi Tb drug resistance: is it really a threat to Africa?
    Paul Nunn
    World Health Organization, Stop TB Department, Avenue Appia 1211 Geneva, Switzerland
    Ethiop Med J 45:399-404. 2007
    ..This paper analyses the threat of TB drug resistance to health and to TB control in Africa, and puts forward measures to diminish this threat...
  11. ncbi HIV infection-associated tuberculosis: the epidemiology and the response
    Haileyesus Getahun
    Stop TB Department, World Health Organization, Geneva, Switzerland
    Clin Infect Dis 50:S201-7. 2010
    ..Use of the highly decentralized TB services as an entry point to rapidly expand access to antiretroviral therapy and methods for prevention of HIV infection must be pursued aggressively...
  12. ncbi Global incidence of multidrug-resistant tuberculosis
    Matteo Zignol
    Stop TB Department, World Health Organization, Geneva 1211, Switzerland
    J Infect Dis 194:479-85. 2006
    ....
  13. ncbi Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes
    Haileyesus Getahun
    Stop TB Department, WHO, Geneva, Switzerland
    Lancet 369:2042-9. 2007
    ..To achieve these goals, greater political commitment, scientific interest, and investment are needed...
  14. ncbi Viewpoint TB diagnostics: what does the world really need?
    Karin Weyer
    Stop TB Department, World Health Organization, Geneva, Switzerland
    J Infect Dis 204:S1196-202. 2011
    ..Development of new technologies, better use of existing tools, and adequate treatment capacity to care for the increasing numbers of cases that will be diagnosed with scale-up of TB diagnostics all need to be addressed simultaneously...
  15. ncbi Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review
    Eline L Korenromp
    Communicable Diseases, Stop TB Department, World Health Organization, Geneva, Switzerland
    Clin Infect Dis 37:101-12. 2003
    ..025). In countries where HIV infection is endemic, TB recurrence may be reduced by administration of rifampin-based treatment for at least 6 months, in accordance with World Health Organization recommendations...
  16. ncbi Multidrug-resistant tuberculosis management in resource-limited settings
    Eva Nathanson
    Stop TB Department, World Health Organization, Geneva, Switzerland
    Emerg Infect Dis 12:1389-97. 2006
    ..In resource-limited settings, treatment of MDRTB provided through, or in collaboration with, national TB programs can yield results similar to those from wealthier settings...
  17. ncbi Opportunities and challenges for HIV care in overlapping HIV and TB epidemics
    Diane V Havlir
    Department of Medicine, University of California, San Francisco, USA
    JAMA 300:423-30. 2008
    ....
  18. ncbi GFATM-WHO partnership: a win for TB-HIV
    Rose Pray
    Int J Tuberc Lung Dis 10:1421. 2006
  19. ncbi How human immunodeficiency virus voluntary testing can contribute to tuberculosis control
    Peter Godfrey-Faussett
    Infectious and Tropical Diseases Department, London School of Hygiene and Tropical Medicine, UK
    IAPAC Mon 9:54-60. 2003
  20. ncbi How human immunodeficiency virus voluntary testing can contribute to tuberculosis control
    Peter Godfrey-Faussett
    Infectious and Tropical Diseases Department, London School of Hygiene and Tropical Medicine, London, England
    Bull World Health Organ 80:939-45. 2002
    ..This will pave the way for large-scale operationalization of the comprehensive range of interventions needed to control TB in settings with high HIV prevalence...
  21. ncbi TB and HIV: joint problems, joint solutions?
    Gijs Elzinga
    Global Working Group on TB HIV, National Institute of Public Health and the Environment, Bilthoven, The Netherlands
    Bull World Health Organ 80:469-70. 2002